Shares of Pinecrest Pharma climbed 6.4% in Thursday trading after announcing a new cost-cutting plan. Analysts said the move reflects shifting sentiment in the biotech sector, with several market watchers noting the stock could see continued attention in coming sessions.
Pinecrest Pharma Shares Climbed 6.4%
About the Author
Other Articles to Read
